Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study.

被引：0
|
作者：
Miguel, Carla
Bratslavsky, Gennady
Jacob, Joseph M.
Grivas, Petros
Spiess, Philippe E.
Necchi, Andrea
Pavlick, Dean C.
Huang, Richard S. P.
Lin, Douglas I.
Danziger, Natalie
Sokol, Ethan
Sivakumar, Smruthy
Graf, Ryon
Vasan, Neil
Ross, Jeffrey S.
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY USA
[2] Univ Washington, Div Oncol, Dept Med, Fred Hutchinson Canc Res Ctr,Clin Res Div, Seattle, WA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS San Raffaele Hosp & Sci Inst, Dept Med Oncol, Milan, Italy
[6] Fdn Med Inc, Cambridge, MA USA
[7] Fdn Med Inc, Morrisville, NC USA
[8] Fdn Med Inc, Boston, MA USA
[9] Columbia Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
258
引用
收藏
页数：1
相关论文
共 9 条
  • [1] Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study
    Basin, Michael F.
    Miguel, Carla M.
    Jacob, Joseph M.
    Goldberg, Hanan
    Grivas, Petros
    Spiess, Philippe E.
    Necchi, Andrea
    Kamat, Ashish M.
    Pavlick, Dean C.
    Huang, Richard S. P.
    Lin, Douglas I.
    Danziger, Natalie
    Sokol, Ethan S.
    Sivakumar, Smruthy
    Graf, Ryon
    Cheng, Liang
    Vasan, Neil
    Ross, Jeffrey
    Basnet, Alina
    Bratslavsky, Gennady
    TARGETED ONCOLOGY, 2024, : 981 - 990
  • [2] Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
    Yasin, Faiza
    Sokol, Ethan
    Vasan, Neil
    Pavlick, Dean C.
    Huang, Richard S. P.
    Pelletier, Maureen
    Levy, Mia Alyce
    Pusztai, Lajos
    Lacy, Jill
    Zhang, Janie Yue
    Ross, Jeffrey S.
    Cecchini, Michael
    ONCOLOGIST, 2024, 29 (12): : 1059 - 1067
  • [3] Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations.
    Cecchini, Michael
    Sokol, Ethan
    Vasan, Neil
    Pavlick, Dean C.
    Huang, Richard S. P.
    Pelletier, Maureen
    Levy, Mia Alyce
    Pusztai, Lajos
    Lacy, Jill
    Eder, Joseph Paul
    Zhang, Janie Yue
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Comparison of genomic alterations (GA) landscape in SPOP mutated (SPOPmut) and SPOP wild type (SPOPwt) clinically advanced prostate cancer (CAPC)
    Bratslavsky, G.
    Spiess, P. E.
    Grivas, P.
    Jacob, J.
    Necchi, A.
    Danziger, N. A.
    Pavlick, D. C.
    Tukachinsky, H.
    Graf, R. P.
    Ross, J. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1180 - S1181
  • [5] Genomic landscape of HER2-negative advanced or metastatic breast cancer with PIK3CA gain-of-function mutations
    Xi, Jing
    Harnden, Kathleen
    Luo, Jingqin
    Call, Greg S.
    Mauer, Elizabeth
    Ronski, Karyn
    Ma, Cynthia X.
    Vasan, Neil
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Characterizing the genomic landscape of PIK3CA alterations from 121,221 adult patients with cancer: The next tissue-agnostic target?
    Coleman, Niamh
    Roszik, Jason
    Reddy, Neha K.
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] The genomic landscape and prognostic implications of somatic alterations in patients (pts) with ER+, HER2-, PIK3CA mutated (mut) advanced breast cancer treated with taselisib and fulvestrant
    Chen, Jessica W.
    Dent, Susan
    Jacot, William
    Cortes, Javier
    Krop, Ian E.
    Stout, Thomas J.
    Schimmoller, Frauke
    Savage, Heidi M.
    Hutchinson, Katherine E.
    Wilson, Timothy R.
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Study of single live circulating tumor cells capture and their genomic profile and enriched mutations of PIK3CA and HRR pathway in patients with breast cancer
    Khandare, Jayant
    Bharde, Atul
    Kishore, Sirish
    Andhari, Saloni
    Khutale, Ganesh
    Jadhav, Bhagwat
    Prajapati, Sangeeta
    Zhou, Wenhui
    Mobeen, Fauzul
    Hariramani, Kanchan
    Basavalingegowda, Madhura
    Jadhav, Vikas Leelavati Balasaheb
    Uttarwar, Mohan
    Joshi, Ashish
    Ghadyalpatil, Nikhil
    Velkuru, Sai Vivek
    Thirumalairaj, Raja
    Shafi, Gowhar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Genomic alterations (GA) in ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) patients (pts) with metastatic breast cancer (MBC): Co-occurrence and prevalence along treatment course
    Bhave, Manali A.
    Quintanilha, Julia
    Ross, Jeffrey S.
    Graf, Ryon P.
    Levy, Mia Alyce
    Kalinsky, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1